{"id":"NCT02162667","sponsor":"Celltrion","briefTitle":"Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer","officialTitle":"Phase 3 Efficacy and Safety Study of CT-P6 and Herceptin as Neoadjuvant and Adjuvant Treatment in Patients With Her2-positive Early Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06","primaryCompletion":"2016-05-26","completion":"2018-10","firstPosted":"2014-06-13","resultsPosted":"2019-10-29","lastUpdate":"2022-08-03"},"enrollment":562,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HER2-positive Carcinoma of Breast"],"interventions":[{"type":"DRUG","name":"Trastuzumab","otherNames":["Herceptin"]}],"arms":[{"label":"CT-P6","type":"EXPERIMENTAL"},{"label":"Trastuzumab","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine whether CT-P6 and Herceptin are equivalent in patients with early-stage breast cancer undergoing neoadjuvant chemotherapy. Our hypothesis is that the pathologic complete response rate will be equivalent in patients treated with neoadjuvant CT-P6 or Herceptin. Patients will receive 8 cycles of neoadjuvant systemic therapy and up to 10 cycles of therapy in the adjuvant setting.","primaryOutcome":{"measure":"The Percentage of Patients Achieving Pathological Complete Response Defined as the Absence of Invasion Tumor Cells in the Breast and in Axillary Lymph Nodes, Regardless of Ductal Carcinoma in Situ (DCIS)","timeFrame":"After Neo-adjuvant therapy and Surgery (up to 30 weeks)","effectByArm":[{"arm":"CT-P6","deltaMin":46.77,"sd":null},{"arm":"Herceptin","deltaMin":50.39,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":98,"countries":["Argentina","Belarus","Bosnia and Herzegovina","Chile","France","Georgia","Hungary","India","Italy","Japan","Latvia","Mexico","Peru","Philippines","Poland","Portugal","Romania","Russia","South Africa","Spain","Taiwan","Ukraine"]},"refs":{"pmids":["34148205","31428820","28592386"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":271},"commonTop":["Alopecia","Neutropenia","Nausea","Anaemia","Fatigue"]}}